Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$238,686
+$117,277 QoQ
Shares Held
199
+50.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#4,323
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hurley Capital, LLC holds $903,759 across 9 Drug Manufacturers - General names. LLY ranks #2 (26.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,247 | $316,700 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
199 | $238,686 | |
| 3 | ABBV |
AbbVie Inc.
|
866 | $217,920 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
518 | $65,444 | |
| 5 | PFE |
Pfizer Inc
|
1,663 | $40,045 | |
| 6 | AMGN |
Amgen Inc
|
47 | $17,019 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
124 | $7,144 | |
| 8 | MRK |
Merck & Co., Inc.
|
4 | $514 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,686 | 199 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $121,409 | 132 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $140,783 | 131 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $97,664 | 128 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $88,866 | 114 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $85,068 | 103 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $156,716 | 203 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||